Emergence of penicillin-resistant Streptococcus pneumoniae ocular infections
- PMID: 9520187
- DOI: 10.1097/00003226-199803000-00003
Emergence of penicillin-resistant Streptococcus pneumoniae ocular infections
Abstract
Background: Approximately 15-20% of Streptococcus pneumoniae clinical isolates in the United States are not susceptible to penicillin. Isolates with a minimum inhibitory concentration (MIC) of 0.12-1.0 mg/ml are intermediately resistant, and those with an MIC > 2.0 microg/ml are classified as having high-level penicillin resistance.
Purpose: We determined the proportion of penicillin-resistant S. pneumoniae recovered from ocular and periocular infections from 1976 through 1995, compared these cases with penicillin-susceptible controls, and evaluated the susceptibility of penicillin-resistant isolates to selected cephalosporins and fluoroquinolones.
Methods: MICs for cephalothin, ceftazidime, ciprofloxacin, and ofloxacin were determined for available isolates by the E test. We performed a case-comparison study to evaluate differences between patients with penicillin-susceptible and -nonsusceptible ocular pneumococcal infections.
Results: Of 173 ocular isolates of S. pneumoniae isolated in the 20-year period, 12 (7%) were not susceptible to penicillin, including eight (5%) intermediate isolates and four (2%) highly resistant isolates. Penicillin-intermediate and -resistant pneumococci were recovered at a rate of none of 46 isolates from 1976 through 1980, one (4%) of 25 from 1981 through 1985, one (2%) of 51 from 1986 through 1990, and 10 (20%) of 51 from 1991 through 1995 (p < 0.0004). We found no significant differences in presenting characteristics between patients with ocular infections due to penicillin-susceptible pneumococci and those caused by nonsusceptible strains. All retested isolates with intermediate susceptibility to penicillin had a cephalothin MIC < or = 1.5 microg/ml, and all retested isolates with high-level penicillin resistance had a cephalothin MIC > or = 4 microg/ml. The ceftazidime MIC for all penicillin-resistant isolates was > or = 24 microg/ml. All penicillin-nonsusceptible isolates had MICs < or = 1.5 microg/ml for ciprofloxacin and < or = 3 microg/ml for ofloxacin.
Conclusion: Penicillin resistance has recently emerged among ocular S. pneumoniae. Cephalothin, ciprofloxacin, and ofloxacin have good activity against some ocular isolates with intermediate penicillin susceptibility, although another agent such as vancomycin may be needed for pneumococci with high-level penicillin-resistance.
Similar articles
-
Antimicrobial resistance in respiratory tract Streptococcus pneumoniae isolates: results of the Canadian Respiratory Organism Susceptibility Study, 1997 to 2002.Antimicrob Agents Chemother. 2003 Jun;47(6):1867-74. doi: 10.1128/AAC.47.6.1867-1874.2003. Antimicrob Agents Chemother. 2003. PMID: 12760860 Free PMC article.
-
Penicillin-resistant Streptococcus pneumoniae in Lebanon: the first nationwide study.Int J Antimicrob Agents. 2006 Mar;27(3):242-6. doi: 10.1016/j.ijantimicag.2005.10.019. Epub 2006 Feb 7. Int J Antimicrob Agents. 2006. PMID: 16464561
-
In vitro activity of selected cephalosporins and erythromycin against staphylococci and pneumococci isolated at 38 North American medical centers participating in the SENTRY Antimicrobial Surveillance Program, 1997-1998.Diagn Microbiol Infect Dis. 2000 Jun;37(2):93-8. doi: 10.1016/s0732-8893(00)00125-5. Diagn Microbiol Infect Dis. 2000. PMID: 10863103
-
In vitro activity of ceftaroline against multidrug-resistant Staphylococcus aureus and Streptococcus pneumoniae: a review of published studies and the AWARE Surveillance Program (2008-2010).Clin Infect Dis. 2012 Sep;55 Suppl 3:S206-14. doi: 10.1093/cid/cis563. Clin Infect Dis. 2012. PMID: 22903953 Review.
-
The approach to treatment of invasive pneumococcal disease in the 1990s.J Ark Med Soc. 1997 Nov;94(6):263-6. J Ark Med Soc. 1997. PMID: 9392928 Review.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Other Literature Sources
Medical